Karen Flick was promoted to General Counsel of Lycia Therapeutics on June 25, 2026, according to GlobeNewswire.
Lycia Therapeutics, a South San Francisco clinical-stage biotechnology company, announced on June 25, 2026 that Karen Flick had been promoted to General Counsel. The announcement accompanied the close of a $75 million Series D financing and the appointment of Amy Bachrodt as Chief Financial Officer. (Source: GlobeNewswire.)
Industry: Biotechnology · Location: South San Francisco, CA · Date: June 25, 2026
Looking for GC or CLO openings? General counsel & CLO jobs · Deputy GC jobs
Who is the general counsel of Lycia Therapeutics?
Karen Flick took the General Counsel role at Lycia Therapeutics in June 2026, as reported by GlobeNewswire. Legal leadership changes often, so check Lycia Therapeutics’s own leadership page for the latest. If you know of a newer move, tell us and we will update the directory.
More general counsel moves
- Janis Benson Named General Counsel of PCS Retirement (June 30, 2026)
- Michael Listgarten Named General Counsel of ALX Oncology (June 30, 2026)
- Eric Martinson Named General Counsel of Headlands Research (June 29, 2026)
- Jeffrey P. Lisenby Named Executive Vice President, General Counsel of EMPLOYERS (June 29, 2026)
- Ben Harshbarger Named Chief Legal Officer of Xilio Therapeutics (June 29, 2026)
Browse every appointment in the General Counsel Directory.
Does this information need updating? Email us at info@inhouseblog.com.